RCM
BSX icon

Rotella Capital Management’s Boston Scientific BSX Stock Holding History

Rotella Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-21,400
Closed -$395K – 41
2015
Q4 		$395K Buy
+21,400
New +$383K 0.35% 140
2015
Q1 		– Sell
-10,000
Closed -$133K – 515
2014
Q4 		$133K Buy
+10,000
New +$128K 0.12% 201

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Rotella Capital Management's BSX Position: Q1 2016 in Review

Rotella Capital Management sold out of Boston Scientific (BSX) in Q1 2016, closing a stake of 21,400 shares — an estimated $395K sold.

Rotella Capital Management first reported a position in BSX in Q4 2014 and held it in 2 quarters. The position peaked at $395K in Q4 2015. 492 funds tracked by Wall St. Rank hold BSX as of Q1 2016.

  • Rotella Capital Management reported no remaining Boston Scientific position as of Q1 2016 after selling out during the quarter.
  • Rotella Capital Management sold 21,400 Boston Scientific shares in Q1 2016, an estimated $395K.
  • Rotella Capital Management first reported a position in Boston Scientific in Q4 2014 and held it in 2 quarters.
  • Rotella Capital Management's Boston Scientific position peaked at $395K in Q4 2015.
  • 492 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2016.

Based on Rotella Capital Management's 13F filing for Q1 2016, filed 13 May 2016.